“showed a trend”

NS-398 showed a trend to reduce inflammation in TNBS colitis rats ( p = 0.064 vs.

Quantitative evaluation of CD68 showed a trend for increased CD68 ( P = 0.064 Mann–Whitney) in these lesions compared with normal cortex, a decline in MAP2 ( P = 0.07, Mann–Whitney) but no significant alteration in GFAP with days post‐injury in this small group (Figure 4 ).

Matched samples of primary tumors and local recurrences were only available for ten patients, but nevertheless showed a trend towards increased expression in local recurrences ( p = 0.064).

In addition to reducing the frequency of stereotyped behaviors such as floor licking and false chewing, sows from the F treatment showed a trend to reduce negative interactions than sows from de C treatment ( p = 0.064).

Subjects on ALSK showed a trend toward a higher HR ( P = 0.064).

We found that 53.5% of the variance in basal mRS (model #2) was explained by HDL, -SH groups, and CMPAase (inversely) and AREase, LOOH, WBC counts and NLR (positively), whilst hypertension showed a trend towards a significant effect ( p = 0.064).

The COI marker showed a trend towards an increase in higher average RNA Shannon Diversity index values compared to the DNA template ( p = 0.064) (Fig. 4 D).

Analysis of clonal heterogeneity in matched DX‐REL samples showed a trend towards reduced entropy levels in REL samples ( P = 0.064), with six of 10 patients showing lower entropy levels in the REL samples (Fig. 6D ), supporting previous data on DX samples of high levels of clonal heterogeneity as a favorable prognostic factor in HHD‐B‐ALL.

When AUROC values of the SOFA score, lactate, and SAH were tested for differences between patient groups with low and high BOD, the mean and NAS of SAH showed a trend toward statistical significance ( p = 0.064 and 0.056, Table 3 ).

A pathological result in the MoCA test was not associated with sex ( p = 0.698) and showed a trend to be more frequent with increasing age ( p = 0.064) or WHO grade ( p = 0.08).

Furthermore, left SII showed a trend for a positive relationship with SPS (r = 0.40, p = 0.064).

Yet, a longer time interval from the last ON showed a trend of less total HRF ( β = −0.05 ± 0.03 [ p = 0.064]).

Although blood glucose analysis revealed no significant main effect for condition and no significant interaction effect, a main effect for time showed a trend against significance ( F (5,95) = 2.17, P = 0.064, η p 2 = 0.10).

The tandem ASCT cohort showed a trend of better 3‐year probability of PFS (58.1% vs. 64.7%, p = 0.064) compared with the single ASCT cohort.

In the model 2 of multivariable analysis, considering the detailed metastatic sites instead of number of metastatic sites, we found exon 21 (HR [95% CI]: 1.56 [1.04–2.36], p = 0.0336), pleural metastasis/effusion (HR [95% CI]: 1.77 [1.17–2.69], p = 0.0075), and bone metastasis (HR [95% CI]: 1.69 [1.13–2.55], p = 0.0116) were independent risk factors for poorer PFS, while dose reduction showed a trend toward better PFS (HR [95% CI]: 0.59 [0.34–1.03], p = 0.0640).

Additionally, while not statistically significant, overt hyperthyroidism showed a trend towards lower insulin resistance in this group (Beta coefficient − 0.262, 95% CI -0.541-0.015, p = 0.064).

The relative abundance of Bacteroides in the FG group was significantly higher than that in the FB group ( P < 0.05), and Faecalibacterium showed a trend of increase ( P = 0.064), and there were no significant differences in other species from the 2 treatments ( P > 0.05).

The EXIT25 showed a trend for an influence of age with a correlation of 0.207 ( p = 0.064).

It was notable that by comparison, S-ALL patients showed a trend of lower WBC ( p = 0.064) and CD19 percentage ( p = 0.065) compared to R-ALL patients but lacked statistical significance.

Although no differences were observed for overall survival ( Figure 2 A,B), patients with low levels of CD47 showed a trend of better progression-free survival ( p = 0.064) ( Figure 2 C) that reached the statistical significance after correcting for the presence of BAP1, GNAQ, and GNA11 mutations ( p = 0.0447) ( Figure 2 D).

HbA1C showed a trend for time × group interaction ( F = 2.523, P = 0.064) (Table 2 ).

The presence of SD showed a trend toward a lower RFS (HR: 2.13; 95% CI: 0.74-6.15; P = .064).

Between group differences assessed with Mann–Whitney U -Test showed that compared to the control group, total AβIR was significantly higher in AD ( p = 0.002), showed a trend with AD-VaD ( p = 0.064) and PSND ( p = 0.076) but not significantly different between PSD and VaD.

Further, When looking at pN3 disease, results showed a trend of differences in OS (P=0.064) and no differences in BCSS (P=0.11) among the three LNR risk groups.

Patients with C1‐INH‐AAE showed a trend for higher occurrence of attacks involving the face (35 versus 21% of attacks; P = 0·064).